Disease activity assessment in rheumatoid arthritis
Author:
- Josef SmolenJSJosef Smolen
- 1 September 2020
- book chapter
- Published by Oxford University Press (OUP)
- p. 161-168
Abstract
The major clinical hallmarks of rheumatoid arthritis (RA) are articular swelling, joint pain, and morning joint stiffness. Disease activity assessment is pivotal when following patients with RA throughout the course of their disease, and especially when assessing improvement or deterioration upon institution of the necessary therapies. To prevent an adverse outcome, it is essential to diagnose the disease early and to start treatment with disease-modifying antirheumatic drugs (DMARDs) immediately after diagnosis. Adhering to the treat-to-target approach, which is a central strategy irrespective of the type of treatment available and the therapy applied, requires consistency in using validated composite measures of disease activity. Rather than a mere matter of using specific therapies, it is also a matter of using tools for disease activity assessment to guide therapeutic decision-making. This enables offering and achieving the best possible outcomes for RA patients.Keywords
This publication has 47 references indexed in Scilit:
- Determining the Minimally Important Difference in the Clinical Disease Activity Index for Improvement and Worsening in Early Rheumatoid Arthritis PatientsArthritis Care & Research, 2015
- American college of rheumatology preliminary definition of improvement in rheumatoid arthritisArthritis & Rheumatism, 1995
- A self‐administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic researchArthritis & Rheumatism, 1995
- Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activityArthritis & Rheumatism, 1995
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995
- Reduced joint counts in controlled clinical trials in rheumatoid arthritisArthritis & Rheumatism, 1994
- The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trialsArthritis & Rheumatism, 1993
- The Rapid Assessment of Disease Activity in Rheumatology (Radar) QuestionnaireArthritis & Rheumatism, 1992
- Measurement of patient outcome in arthritisArthritis & Rheumatism, 1980
- A Seven‐Day variability study of 499 patients with peripheral rheumatoid arthritisArthritis & Rheumatism, 1965